{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:43:05Z","timestamp":1791409385027,"version":"4.3.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:00:00Z","timestamp":1328572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:00:00Z","timestamp":1328572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/leu.2012.24","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T07:40:17Z","timestamp":1328600417000},"page":"1576-1583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration"],"prefix":"10.1038","volume":"26","author":[{"given":"J","family":"Hoellenriegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G P","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sivina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ravandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W G","family":"Wierda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,7]]},"reference":[{"key":"BFleu201224_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804\u2013815.","journal-title":"N Engl J Med"},{"key":"BFleu201224_CR2","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","volume":"23","author":"MJ Keating","year":"2005","unstructured":"Keating MJ, O\u2019Brien S, Albitar M, Lerner S, Plunkett W, Giles F et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 4079\u20134088.","journal-title":"J Clin Oncol"},{"key":"BFleu201224_CR3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","volume":"376","author":"M Hallek","year":"2010","unstructured":"Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010; 376: 1164\u20131174.","journal-title":"Lancet"},{"key":"BFleu201224_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/28.8.7003001","volume":"28","author":"H Stein","year":"1980","unstructured":"Stein H, Bonk A, Tolksdorf G, Lennert K, Rodt H, Gerdes J . Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem 1980; 28: 746\u2013760.","journal-title":"J Histochem Cytochem"},{"key":"BFleu201224_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI23409","volume":"115","author":"BT Messmer","year":"2005","unstructured":"Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755\u2013764.","journal-title":"J Clin Invest"},{"key":"BFleu201224_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","volume":"32","author":"P Ghia","year":"2002","unstructured":"Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 2002; 32: 1403\u20131413.","journal-title":"Eur J Immunol"},{"key":"BFleu201224_CR7","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","volume":"111","author":"PE Patten","year":"2008","unstructured":"Patten PE, Buggins AG, Richards J, Wotherspoon A, Salisbury J, Mufti GJ et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 2008; 111: 5173\u20135181.","journal-title":"Blood"},{"key":"BFleu201224_CR8","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-06-1204","volume":"12","author":"J Ruan","year":"2006","unstructured":"Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M et al. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. Clin Cancer Res 2006; 12: 5622\u20135631.","journal-title":"Clin Cancer Res"},{"key":"BFleu201224_CR9","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","volume":"110","author":"A Burkle","year":"2007","unstructured":"Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA . Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007; 110: 3316\u20133325.","journal-title":"Blood"},{"key":"BFleu201224_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/leu.2010.306","volume":"25","author":"N Bhattacharya","year":"2011","unstructured":"Bhattacharya N, Diener S, Idler IS, Barth TF, Rauen J, Habermann A et al. Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood. Leukemia 2011; 25: 722\u2013726.","journal-title":"Leukemia"},{"key":"BFleu201224_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M . B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Ann Rev Immunol 2003; 21: 841\u2013894.","journal-title":"Ann Rev Immunol"},{"key":"BFleu201224_CR12","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","volume":"103","author":"FK Stevenson","year":"2004","unstructured":"Stevenson FK, Caligaris-Cappio F . Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004; 103: 4389\u20134395.","journal-title":"Blood"},{"key":"BFleu201224_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011; 117: 563\u2013574.","journal-title":"Blood"},{"key":"BFleu201224_CR14","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","volume":"100","author":"L Chen","year":"2002","unstructured":"Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002; 100: 4609\u20134614.","journal-title":"Blood"},{"key":"BFleu201224_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639\u20131647.","journal-title":"J Exp Med"},{"key":"BFleu201224_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","volume":"114","author":"MP Quiroga","year":"2009","unstructured":"Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood 2009; 114: 1029\u20131037.","journal-title":"Blood"},{"key":"BFleu201224_CR17","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1182\/blood-2009-07-233692","volume":"115","author":"M Buchner","year":"2010","unstructured":"Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T et al. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 2010; 115: 4497\u20134506.","journal-title":"Blood"},{"key":"BFleu201224_CR18","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","volume":"115","author":"JW Friedberg","year":"2010","unstructured":"Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A et al. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 2010; 115: 2578\u20132585.","journal-title":"Blood"},{"key":"BFleu201224_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1124\/jpet.106.109058","volume":"319","author":"S Braselmann","year":"2006","unstructured":"Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Baluom M et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther 2006; 319: 998\u20131008.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu201224_CR20","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1182\/blood-2010-03-274969","volume":"117","author":"MP Reilly","year":"2011","unstructured":"Reilly MP, Sinha U, Andre P, Taylor SM, Pak Y, Deguzman FR et al. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood 2011; 117: 2241\u20132246.","journal-title":"Blood"},{"key":"BFleu201224_CR21","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1182\/blood-2011-06-360743","volume":"118","author":"P Andre","year":"2011","unstructured":"Andre P, Morooka T, Sim D, Abe K, Lowell C, Nanda N et al. Critical role for Syk in responses to vascular injury. Blood 2011; 118: 5000\u20135010.","journal-title":"Blood"},{"key":"BFleu201224_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1124\/jpet.111.188441","volume":"340","author":"G Coffey","year":"2011","unstructured":"Coffey G, Deguzman F, Inagaki M, Pak Y, Delaney SM, Ives D et al. Specific inhibition of Syk suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. J Pharmacol Exp Ther 2011; 340: 350\u2013359.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu201224_CR23","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1182\/blood-2011-02-333773","volume":"118","author":"S Cheng","year":"2011","unstructured":"Cheng S, Coffey G, Zhang XH, Shaknovich R, Song Z, Lu P et al. SYK inhibition and response prediction in diffuse large B-cell lymphoma. Blood 2011; 118: 6342\u20136352.","journal-title":"Blood"},{"key":"BFleu201224_CR24","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","volume":"96","author":"JA Burger","year":"2000","unstructured":"Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell\u2019Aquila M, Kipps TJ . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000; 96: 2655\u20132663.","journal-title":"Blood"},{"key":"BFleu201224_CR25","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","volume":"113","author":"JA Burger","year":"2009","unstructured":"Burger JA, Quiroga MP, Hartmann E, Burkle A, Wierda WG, Keating MJ et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 2009; 113: 3050\u20133058.","journal-title":"Blood"},{"key":"BFleu201224_CR26","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","volume":"94","author":"JA Burger","year":"1999","unstructured":"Burger JA, Burger M, Kipps TJ . Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999; 94: 3658\u20133667.","journal-title":"Blood"},{"key":"BFleu201224_CR27","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","volume":"118","author":"J Hoellenriegel","year":"2011","unstructured":"Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ et al. The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood 2011; 118: 3603\u20133612.","journal-title":"Blood"},{"key":"BFleu201224_CR28","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","volume":"117","author":"M Sivina","year":"2011","unstructured":"Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S et al. CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood 2011; 117: 1662\u20131669.","journal-title":"Blood"},{"key":"BFleu201224_CR29","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2010-07-295659","volume":"117","author":"G Pearce","year":"2011","unstructured":"Pearce G, Audzevich T, Jessberger R . SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70. Blood 2011; 117: 1574\u20131584.","journal-title":"Blood"},{"key":"BFleu201224_CR30","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","volume":"111","author":"L Chen","year":"2008","unstructured":"Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230\u20132237.","journal-title":"Blood"},{"key":"BFleu201224_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463: 88\u201392.","journal-title":"Nature"},{"key":"BFleu201224_CR32","doi-asserted-by":"publisher","first-page":"32a","DOI":"10.1182\/blood-2010-04-279935","volume":"116","author":"JA Burger","year":"2010","unstructured":"Burger JA, O\u2019Brien S, Fowler N, Advani R, Sharman JP, Furman RR et al. The Bruton's tyrosine kinase inhibitor, PCI-32765, is well tolerated and demonstrates promising clinical activity in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): an update on ongoing phase 1 studies. Blood 2010; 116: 32a.","journal-title":"Blood"},{"key":"BFleu201224_CR33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","volume":"363","author":"ME Weinblatt","year":"2011","unstructured":"Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB, Magilavy DB . An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N Engl J Med 2011; 363: 1303\u20131312.","journal-title":"N Engl J Med"},{"key":"BFleu201224_CR34","first-page":"31a","volume":"116","author":"RR Furman","year":"2010","unstructured":"Furman RR, Byrd JC, Brown JR, Coutre SE, Benson Jr DM, Wagner-Johnston ND et al. CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110 {delta}, demonstrates clinical activity and pharmacodynamic effects in patients with relapsed or refractory chronic lymphocytic leukemia. Blood 2010; 116: 31a.","journal-title":"Blood"},{"key":"BFleu201224_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","volume":"117","author":"BJ Lannutti","year":"2011","unstructured":"Lannutti BJ, Meadows SA, Herman SE, Kashishian A, Steiner B, Johnson AJ et al. CAL-101, a p110 {delta} selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood 2011; 117: 591\u2013594.","journal-title":"Blood"},{"key":"BFleu201224_CR36","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1158\/0008-5472.CAN-08-4252","volume":"69","author":"M Buchner","year":"2009","unstructured":"Buchner M, Fuchs S, Prinz G, Pfeifer D, Bartholome K, Burger M et al. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res 2009; 69: 5424\u20135432.","journal-title":"Cancer Res"},{"key":"BFleu201224_CR37","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.4049\/jimmunol.176.10.5715","volume":"176","author":"M Gururajan","year":"2006","unstructured":"Gururajan M, Jennings CD, Bondada S . Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma. J Immunol 2006; 176: 5715\u20135719.","journal-title":"J Immunol"},{"key":"BFleu201224_CR38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.346","volume":"23","author":"S Gobessi","year":"2009","unstructured":"Gobessi S, Laurenti L, Longo PG, Carsetti L, Berno V, Sica S et al. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia 2009; 23: 686\u2013697.","journal-title":"Leukemia"},{"key":"BFleu201224_CR39","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/onc.2009.179","volume":"28","author":"AD Baudot","year":"2009","unstructured":"Baudot AD, Jeandel PY, Mouska X, Maurer U, Tartare-Deckert S, Raynaud SD et al. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene 2009; 28: 3261\u20133273.","journal-title":"Oncogene"},{"key":"BFleu201224_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ni1365","volume":"7","author":"G Pearce","year":"2006","unstructured":"Pearce G, Angeli V, Randolph GJ, Junt T, von Andrian U, Schnittler HJ et al. Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nat Immunol 2006; 7: 827\u2013834.","journal-title":"Nat Immunol"},{"key":"BFleu201224_CR41","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","volume":"162","author":"R Krzysiek","year":"1999","unstructured":"Krzysiek R, Lefevre EA, Zou W, Foussat A, Bernard J, Portier A et al. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J Immunol 1999; 162: 4455\u20134463.","journal-title":"J Immunol"},{"key":"BFleu201224_CR42","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2011-03-339077","volume":"118","author":"XC Badoux","year":"2011","unstructured":"Badoux XC, Keating MJ, Wen S, Lee BN, Sivina M, Reuben J et al. Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia. Blood 2011; 118: 3489\u20133498.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201224","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T10:32:30Z","timestamp":1686738750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFleu201224"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.24","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,7]]},"assertion":[{"value":"23 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JH, MS, AF, FR, WGW, MJK, SOB and JAB declare no conflict of interest. GPC, US and AP are employees and shareholders of Portola Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}